News und Analysen
EQS-News: Dermapharm Holding SE hits upper end of guidance range for adjusted EBITDA, primarily due to steadily growing international presence in branded business
EQS-News: Dermapharm Holding SE hits upper end of guidance range for adjusted EBITDA, primarily due to steadily growing international presence in branded business
EQS-News: Dermapharm Holding SE builds on success in Q3 2023
EQS-News: Dermapharm Holding SE builds on success in Q3 2023
EQS-News: Dermapharm Holding SE publishes H1 2023 financial report, confirms outlook for 2023 overall
EQS-News: Dermapharm Holding SE publishes H1 2023 financial report, confirms outlook for 2023 overall
EQS-News: Dermapharm Holding SE: First half of 2023 is a success despite the challenging market environment
EQS-News: Dermapharm Holding SE: First half of 2023 is a success despite the challenging market environment
EQS-News: Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 1.05 per share
EQS-News: Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 1.05 per share
EQS-News: Dermapharm Holding SE invests in family-owned Austrian pharmaceutical company Montavit
EQS-News: Dermapharm Holding SE invests in family-owned Austrian pharmaceutical company Montavit
EQS-News: Dermapharm Holding SE: outstanding start to financial year 2023
EQS-News: Dermapharm Holding SE: outstanding start to financial year 2023
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE surpasses one billion in revenue for first time in 2022 and maintains growth trajectory
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE surpasses one billion in revenue for first time in 2022 and maintains growth trajectory
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE's revenue exceeds one billion for the first time
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE's revenue exceeds one billion for the first time
EQS-News: Dermapharm Holding SE intensifies its internationalisation efforts by acquiring Arkopharma
EQS-News: Dermapharm Holding SE intensifies its internationalisation efforts by acquiring Arkopharma
EQS-News: Dermapharm Holding SE successfully maintains growth trend as planned
EQS-News: Dermapharm Holding SE successfully maintains growth trend as planned
DGAP-News: Dermapharm Holding SE publishes H1 2022 financial report, confirms outlook for 2022 overall
DGAP-News: Dermapharm Holding SE publishes H1 2022 financial report, confirms outlook for 2022 overall
DGAP-News: Dermapharm Holding SE: Successful first half of 2022 in challenging market environment
DGAP-News: Dermapharm Holding SE: Successful first half of 2022 in challenging market environment
DGAP-News: Dermapharm commits to acquire the French market leader for herbal medicinal products and food supplements
DGAP-News: Dermapharm commits to acquire the French market leader for herbal medicinal products and food supplements
DGAP-Adhoc: Dermapharm Holding SE: binding offer to acquire Arkopharma Group
DGAP-Adhoc: Dermapharm Holding SE: binding offer to acquire Arkopharma Group
DGAP-News: Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 2.17 per share
DGAP-News: Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 2.17 per share
DGAP-News: Dermapharm Holding SE: excellent start into financial year 2022
DGAP-News: Dermapharm Holding SE: excellent start into financial year 2022
DGAP-News: Dermapharm Holding SE: 2021 erfolgreichstes Jahr der Firmengeschichte - kontinuierliches Wachstum im Geschäftsjahr 2022
DGAP-News: Dermapharm Holding SE: 2021 erfolgreichstes Jahr der Firmengeschichte - kontinuierliches Wachstum im Geschäftsjahr 2022
DGAP-News: Dermapharm Holding SE records best ever year in 2021 - continuous growth in financial year 2022
DGAP-News: Dermapharm Holding SE records best ever year in 2021 - continuous growth in financial year 2022
DGAP-News: Dermapharm Holding SE: Continuous growth of Group revenues and adjusted Group EBITDA in 2022
DGAP-News: Dermapharm Holding SE: Continuous growth of Group revenues and adjusted Group EBITDA in 2022
DGAP-News: Dermapharm Holding SE: Kontinuierliches Wachstum von Konzernumsatz und bereinigtem Konzern-EBITDA in 2022
DGAP-News: Dermapharm Holding SE: Kontinuierliches Wachstum von Konzernumsatz und bereinigtem Konzern-EBITDA in 2022
DGAP-News: Dermapharm Holding SE: Most successful business year in the company's history - Adjusted Group EBITDA at the upper end of the outlook
DGAP-News: Dermapharm Holding SE: Most successful business year in the company's history - Adjusted Group EBITDA at the upper end of the outlook
DGAP-News: Dermapharm Holding SE: Erfolgreichstes Geschäftsjahr der Firmengeschichte - bereinigtes Konzern-EBITDA am oberen Ende der Prognose
DGAP-News: Dermapharm Holding SE: Erfolgreichstes Geschäftsjahr der Firmengeschichte - bereinigtes Konzern-EBITDA am oberen Ende der Prognose
DGAP-News: Dermapharm successfully acquires C³ Group
DGAP-News: Dermapharm successfully acquires C³ Group